Activation in M1 but not M2 macrophages contributes to cardiac remodeling after myocardial infarction in rats: A critical role of the calcium sensing receptor/NRLP3 inflammasome

Cellular Physiology and Biochemistry

Volumn 35, Issue 6, 2015, Pages 2483-2500

  Liu, Wenxiu ^a   Zhang, Xin ^a   Zhao, Meng ^a   Zhang, Xiaohui ^a   Chi, Jinyu ^a   Liu, Yue ^a   Lin, Fang ^a   Fu, Yu ^a   Ma, Dandan ^a   Yin, Xinhua ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Calcium sensing receptor; Cardiac remodeling; Macrophage; Myocardial infarction; NLRP3 inflammasome

Indexed keywords

CALCIUM; CALCIUM SENSING RECEPTOR; COLLAGEN; GELATINASE A; INFLAMMASOME; INFLAMMASOME NRLP3; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; ACTIN; CARRIER PROTEIN; EXTRACELLULAR CALCIUM CATION-SENSING RECEPTOR, RAT; GELATINASE B; NOD-LIKE RECEPTOR 3, RAT; SMOOTH MUSCLE ACTIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL ACTIVATION; CELL INFILTRATION; CELL INVASION; CELL POLARITY; CELL SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; HEART INFARCTION; HEART VENTRICLE REMODELING; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INVESTIGATIVE PROCEDURES; LIMIT OF QUANTITATION; MACROPHAGE; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN SECRETION; RANDOMIZED CONTROLLED TRIAL; RAT; UPREGULATION; WESTERN BLOTTING; ANIMAL; CARDIAC MUSCLE; FIBROBLAST; FIBROSIS; HEART; HEART VENTRICLE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; WISTAR RAT;

RATTUS;

ACTINS; ANIMALS; CARRIER PROTEINS; COLLAGEN; DOWN-REGULATION; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBROSIS; HEART; HEART VENTRICLES; INFLAMMASOMES; INTERLEUKIN-1BETA; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, WISTAR; RECEPTORS, CALCIUM-SENSING; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-2; UP-REGULATION; VENTRICULAR REMODELING;

EID: 84931357397     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000374048     Document Type: Article

References (52)

1. Entman ML, Smith CW: Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res 1994;28:1301-1311.
2. Mehta JL, Li DY: Inflammation in ischemic heart disease: response to tissue injury or a pathogenetic villain? Cardiovasc Res 1999;43:291-299.
3. Lambert JM, Lopez EF, Lindsey ML: Macrophage roles following myocardial infarction. Int J Cardiol 2008;130:147-158.
4. Nahrendorf M, Pittet MJ, Swirski FK: Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 2010;121:2437-2445.
5. Guillen I, Blanes M, Gomez-Lechon MJ, Castell JV: Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6. Am J Physiol 1995;269:R229-235.
6. Herskowitz A, Choi S, Ansari AA, Wesselingh S: Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 1995;146:419-428.
7. Bujak M, Dobaczewski M, Chatila K, Mendoza LH, Li N, Reddy A, Frangogiannis NG: Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol 2008;173:57-67.
8. Van Tassell BW, Varma A, Salloum FN, Das A, Seropian IM, Toldo S, Smithson L, Hoke NN, Chau VQ, Robati R, Abbate A: Interleukin-1 trap attenuates cardiac remodeling after experimental acute myocardial infarction in mice. J Cardiovasc Pharmacol 2010;55:117-122.
9. Abbate A, Van Tassell BW, Seropian IM, Toldo S, Robati R, Varma A, Salloum FN, Smithson L, Dinarello CA: Interleukin-lbeta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse. Eur J heart Fail 2010;12:319-322.
10. Toldo S, Mezzaroma E, Van Tassell BW, Farkas D, Marchetti C, Voelkel NF, Abbate A: Interleukin-lfi blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse. Exp Physiol 2013;98:734-745.
11. Kate Schroder, Jurg Tschopp: The Inflammasomes. Cell 2010;140:821-832.
12. Fayyaz SS, Yasunori Ogura, Marian Szczepanik, Lara-Tejero M, Lichtenberger GS, Grant EP, Bertin J, Coyle AJ, Galan JE, Askenase PW, Flavell RA: Critical Role for NALP3/CIASl/Cryopyrin in Innate and Adaptive Immunity through Its Regulation of Caspase-1. Immunity 2006;24:317-327.
13. Sandanger 0, Ranheim T, Vinge LE, Bliks0en M, Alfsnes K, Finsen AV, Dah CP, Askevold ET, Florholmen G, Christensen G, Fitzgerald KA, Lien E, Valen G, Espevik T, Aukrust P, Yndestad A: The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischemia-reperfusion injury. Cardiovasc Res 2013;99:164-174.
14. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor 0, Sun A, Hediger MA, Lytton J, Hebert S: Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993;366:575-580.
15. Brown EM, Vassilev PM, Quinn S, Hebert SC: G-protein-coupled, extracellular Ca2+ -sensing receptor: a versatile regulator of diverse cellular functions. Vitam Horm 1999;55:1-71.
16. Lin KI, Chattopadhyay N, Bai M, Alvarez R, Dang CV, Baraban JM, Brown EM, Ratan RR: Elevated extracellular calcium can prevent apoptosis via the calcium-sensing receptor. Biochem Biophys Res Commun 1998;249:325-331.
17. Lu FH, Fu SB, Leng XN, Zhang X, Dong S, Zhao YJ, Ren H, Li H, Zhong X, Xu CQ, Zhang WH: Calcium-sensing Receptor in Cardiomyocyte Apoptosis via the Sarcoplasmic Retiuclum and Mitochondrial Death Pathway in Cardiac hypertrophy and heart Failure. Cell Physiol Bilchem 2013;31:728-743.
18. Xi YH, Li HZ, Zhang WH, Wang LN, Zhang L, Lin Y, Bai SZ, Li HX, Wu LY, Wang R, Xu CQ: The functional expression of calcium-sensing receptor in the differentiated THP-1 cells. Mol Cell Biochem 2010;342:233-240.
19. Lee GS, Subramanian N, Kim AI, Aksentijevich I, Goldbach-Mansky R, Sacks DB, Germain RN, Kastner DL, Chae JJ: The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 2012;492:123-127.
20. Huang NF, Sievers RE, Park JS, Fang Q, Li S, Lee RJ: A rodent model of myocardial infarction for testing the efficacy of cells and polymers for myocardial reconstruction: Nat Protoc 2006;1:1596-1609.
21. Wang YL, Malik AB, Sun Y, Hu S, Reynolds AB, Minshall RD, Hu Gl: Innate immune function of the adherents junction protein pl20-catenin in endothelial response to endotoxin. J Immunol 2011;186:3180-3187.
22. Huang XR, Chung AC, Yang F, Yue W, Deng C, Lau CP, Tse HF, Lam JY: Smad3 mediates cardiac and fibrosis in angiotensin II-induced hypertensive cardiac remodeling. Hypertension 2010;55:1165-1171.
23. Matsuura M, Saito S, Hirai Y, Okamua H: A pathway through interferon-gamma is the main pathway for induction of nitric oxide upon stimulation with bacterial lipopolysaccharide in mouse peritoneal cells. Eur J Biochem 2003;270:4016-4025.
24. Tjiu JW, Chen JS, Shun CT, Lin SJ, Liao YH, Chu CY, Tsai TF, Chiu HC, Dai YS, Inoue H, Yang PC, Kuo ML, Jee SH: Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. J Invest Dermatol 2009;129:1016-1025.
25. Tomoko Satomi, Mikako Ogawa, Ikuo Mori, Ishino S, Kubo K, Magata Y, Nishimoto T: Comparison of Contrast Agents for Atherosclerosis Imaging Using Cultured Macrophages: FDG Versus Ultrasmall Superparamagnetic Iron Oxide. J Nucl Med 2013;54: 999-1004.
26. Olson ER, Shamhart PE, Naugle JE, Meszaros JG: Angiotensin II-induced extracellular signal-regulated kinase 1/2 activation is mediated by protein kinase c delta and intracellular calcium in adult rat cardiac fibroblasts. Hypertension 2008;51:704-711.
27. Ieda M, Tsuchihashi T, Ivey KN, Ross RS, Hong TT, Shaw RM, Sricastava D: Cardiac fibroblasts regulate myocardial proliferation through betal integrin signaling. Dev Cell 2009;16:233-244.
28. Sun B, Huo R, Sheng Y, Li Y, Xie X, Chen C, Liu HB, Li N, Li CB, Guo WT, Zhu JX, Yang BF, Dong DL: Bone morphogenetic protein-4 mediates cardiac hypertrophy apoptosis, and fibrosis in experimentally pathological cardiachypertrophy. Hypertension 2013;61:352-360.
29. Tsujita K, Kaikita K, Hayasaki T, Honda T, Kobayashi H, Sakashita N, Suzuki H, Kodama T, Ogawa H, Takeya M: Targeted deletion of class a macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction. Circulation 2007;115:1904-1911.
30. Squadrito F, Altavilla D, Squadrito G, Campo GM, Arlotta M, Arcoraci V, Minutoli L, Serrano M, Saitta A, Caputi AP: 17beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat. Eur J Pharmacol 1997;335: 185-192.
31. Yan X, Anzai A, Katsumata Y, Matsuhashi T, Ito K, Endo J, Yamamoto T, Takeshima A, Shinmura K, Shen W Fukuda K, Sano M: Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J Mol Cell Cardiol 2013;62:24-35.
32. Martinez FO, Sica A, Mantovani A, Locati M: Macrophage activation and polarization. Front Biosci 2008;13:453-461.
33. Pelegrin P, Surprenant A: Dynamics of macrophage polarization reveal new mechanism to inhibit IL-lbeta release through pyrophosphates. EMBO J 2009;28:2114-2127.
34. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA, March CJ, Kronheim SR, Druck T, Cannizzaro LA, Huebner K, Black RA: Molecular cloning of the interleukin-1 beta converting enzyme. Science 1992;3 256:97-100.
35. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Elliston KO, Ayala JM, Casano FJ,Chin J, Ding GJF, Egger LA, Gaffney EP, Limjuco G, Palyha OC, Raju SM, Rolando AM, Salley JP, Yamin TT,Lee TD, Shively JE, MacCross M, Mumford RA, Schmidt JA, Toccill MJ: A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992;30 356:768-774.
36. Wang R, Xu C, Zhao W, Zhang J, Cao K, Yang B, Wu L: Calcium and polyamine regulated calcium-sensing receptors in cardiac tissues. Eur J Biochem 2003;270:2680-2688.
37. Hofer AM, Brown EM: Extracellular calcium sensing and signalling. Nature Rev Mol. Cell Biol 2003;4:530-538.
38. Murakami T, Ockinger J, Yu J, Byles V, McColl A, Hofer AM, Horng T: Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc Natl Acad Sci USA 2012;109:11282-11287.
39. Netea MG, Nold-Petry CA, Nold MF, Joosten LA, Opitz B, van der Meer JH, van de Veerdonk FL, Ferwerda G, Heinhuis B, Devesa I, Funk CJ, Mason RJ,Kullberg BJ, Rubartelli A, van der Meer JW, Dinarello CA: Differential requirement for the activation of the inflammasome for processing and release of IL-1 in monocytes and macrophages. Blood 2009;113:2324-2335.
40. Latz E, Xiao TS, Stutz A: Activation and regulation of the inflammasomes. Nat Rev Immunol 2013;13:397-411.
41. Rossol M, Pierer M, Raulien N, Quandt D, Meusch U, Rothe K, Schubert K, Schoneberg T, Schaefer M, Krugel U, Smajilovic S, Brauner-Osborne H, Baerwald C, Wagner U: Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors. Nat Commun 2012;3:1329.
42. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, Hornung V, Latz E: NF-kB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009;183:787-791.
43. Franchi L, Eigenbrod T, Nunez G: TNF-a Mediate Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation. J Immunol 2009;183:792-796.
44. Masafumi Takahashi: NLRP3 in myocardial ischemia reperfusion injury: inflammasomes-dependent or -independent role in different cell type. Cardiovasc Res 2013;99:4-5.
45. Sandanger 0, Ranheim T, Vinge LE, Bliks0en M, Alfsnes K, Finsen AV, Dahl CP, Askevold ET, Florholmen G, Christensen G, Fitzgerald KA, Lien E, Valen G,Espevik T, Aukrust P, Yndestad A: The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Cardiovasc Res 2013;99:164-174.
46. Mezzaroma E, Toldo S, Farkas D, Seropian IM, Van Tassell BW, Salloum FN, Kannan HR, Menna AC, Voelkel NF, Abbate A: The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc Natl Acad Sci USA 2011;108:19725-19730.
47. Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, Morimoto H, Izawa A, Takahashi Y, Masumoto J, Koyama J, Hongo M, Noda T, Nakayama J, Sagara J, Taniguchi S, Ikeda U: Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 2011;123:594-604.
48. Mezzaroma E, Toldo S, Abbate A: Role of NLRP3 (cryopyrin) in acute myocardial infarction. Cardiovasc Res 2013;99:225-226.
49. Swynghedauw B: Molecular mechanisms of myocardial remodeling. Physiol Rev 1999;79:215-262.
50. Manable I,Shindo T, Nagai R: Gene Expression in Fibroblasts and Fibrosis:Involvement in Cardiac hypertrophy. Circ Res 2002;91:1103-1113.
51. Bujak M, Dobaczewski M, Chatila K,Mendoza LH, Li N, Reddy A, Frangogiannis NG: Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol 2008;173:57-67.
52. Frangogiannis NG: The immune system and cardiac repair. Pharmacol Res 2008;58:88-111.